|
1
|
Limited Sampling Strategy for Accurate Prediction of Pharmacokinetics of Saroglitazar: A 3-point Linear Regression Model Development and Successful Prediction of Human Exposure. Clin Ther 2018; 40:456-468.e1. [DOI: 10.1016/j.clinthera.2018.01.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2017] [Revised: 01/17/2018] [Accepted: 01/27/2018] [Indexed: 12/13/2022]
|
|
2
|
Bhamidipati RK, Syed M, Mullangi R, Srinivas N. Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models. Xenobiotica 2017; 48:148-156. [DOI: 10.1080/00498254.2017.1294278] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Affiliation(s)
| | - Muzeeb Syed
- Department of Pharmaceutics, University of Florida, FL, USA, and
| | - Ramesh Mullangi
- Drug Metabolism and Pharmacokinetics, Jubilant Biosys Ltd, Bangalore, Karnataka, India,
| | | |
Collapse
|